References
- Fishman GI, Chugh SS, Dimarco JP, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122:2335–2348.
- Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009–1017.
- Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation. 1995;92:1651–1664.
- Moss AJ, Schuger C, Beck CA, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275–2283.
- Sweeney MO. The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death. Circulation. 2010;122:2638–2641.
- Topaloglu S, Aras D, Sahin O, et al. QT dispersion significantly increases after implantable cardioverter-defibrillator shocks. Ann Noninvasive Electrocardiol. 2007;12:44–49.
- Gurevitz O, Yaacoby E, Segal E, et al. Effect of implantable cardioverter-defibrillator shocks on QT dispersion. Am J Cardiol. 2000;86:1146–1148. A9.
- Moubarak JB, Karasik PE, Fletcher RD, et al. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation. J Am Coll Cardiol. 2000;35:422–427.
- Sweeney MO. Point: implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias increase mortality. Heart Rhythm. 2012;9:985–987.
- Hnatkova K, Ryan SJ, Bathen J, et al. T-wave morphology differences between patients with and without arrhythmic complication of ischemic heart disease. J Electrocardiol. 2001;34 Suppl:113–117.
- Zabel M, Malik M, Hnatkova K, et al. Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veterans. Circulation. 2002;105:1066–1070.
- Reddy BR, Xue Q, Zywietz C. Analysis of interval measurements on CSE multilead reference ECGs. J Electrocardiol. 1996;29 Suppl:62–66.
- Johannesen L, Garnett C, Malik M. Electrocardiographic data quality in thorough QT/QTc studies. Drug Saf. 2014;37:191–197.
- Malik M, Acar B, Gang Y, et al. QT dispersion does not represent electrocardiographic interlead heterogeneity of ventricular repolarization. J Cardiovasc Electrophysiol. 2000;11:835–843.
- Batchvarov V, Hnatkova K, Malik M. Assessment of noise in digital electrocardiograms. Pacing Clin Electrophysiol. 2002;25:499–503.
- Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36:1749–1766.
- Pang Y, Jin Q, Zhang N, et al. High-energy defibrillation increases the dispersion of regional ventricular repolarization. J Interv Card Electrophysiol. 2011;32:81–86.
- Lampert R, Soufer R, McPherson CA, et al. Implantable cardioverter-defibrillator shocks increase T-wave alternans. J Cardiovasc Electrophysiol. 2007;18:512–517.
- Zabel M, Acar B, Klingenheben T, et al. Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction. Circulation. 2000;102:1252–1257.
- Ruwald AC, Schuger C, Moss AJ, et al. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol. 2014;7:785–792.
- Powell BD, Saxon LA, Boehmer JP, et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013;62:1674–1679.
- Gasparini M, Proclemer A, Klersy C, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA. 2013;309:1903–1911.
- Cay S, Canpolat U, Ucar F, et al. Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bYInCreaseD zones) trial. Am J Cardiol. 2015;115:1235–1243.